Skip to main content
Clinical Trials/NL-OMON54476
NL-OMON54476RecruitingNot Applicable

An intervention study on the effect of digital self-monitoring-based management of relapsing and remitting multiple sclerosis on self-efficacy, clinical outcomes and cost-effectiveness - Multiple sclerosis self-monitoring (MSSM)

Vrije Universiteit Medisch Centrum0 sites210 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
210

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • 1. A minimum age of 18 years.
  • 2. Have a definite diagnosis of RRMS according to the revised McDonald 2017
  • 3. Have a length of disease duration of >=12 months, from date of MS diagnosis.
  • 4. Have clinical disease activity (reported relapses) and/or radiological
  • disease activity (new/enlarged T2 lesions or contrast-enhancing lesions) within
  • the past 12 months.
  • 5. Willing and able to install and use MS sherpa on own smartphone with Android
  • (version 4.4 or higher) or iOS (version 9 or higher) operating system.
  • 6. Willing to stay for treatment with the same hospital during the year of
  • 7. Willing to follow the rules of conduct as described in Appendix A during the
  • year of study.

Exclusion Criteria

  • 1. EDSS of > 6.5 at baseline screening. 2. Presence of a cognitive, visual
  • or upper extremity deficit that disables the use or measurements of MS sherpa
  • on the smartphone, as judged by the investigator. 3. Concomitant use of health
  • monitoring apps or devices for MS during the study. 4. Concomitant
  • participation in another intervention trial in MS.

Investigators

Similar Trials